Integra Lifesciences Holdings Corp (IART)
22.99
+0.06
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Gross Profit Margin (Quarterly): 52.58% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 52.58% |
| June 30, 2024 | 54.02% |
| March 31, 2024 | 56.07% |
| December 31, 2023 | 57.05% |
| September 30, 2023 | 57.10% |
| June 30, 2023 | 54.30% |
| March 31, 2023 | 61.15% |
| December 31, 2022 | 62.83% |
| September 30, 2022 | 61.46% |
| June 30, 2022 | 62.70% |
| March 31, 2022 | 62.15% |
| December 31, 2021 | 61.47% |
| September 30, 2021 | 62.66% |
| June 30, 2021 | 61.21% |
| March 31, 2021 | 59.50% |
| December 31, 2020 | 62.16% |
| September 30, 2020 | 63.59% |
| June 30, 2020 | 59.22% |
| March 31, 2020 | 62.33% |
| December 31, 2019 | 62.17% |
| September 30, 2019 | 62.37% |
| June 30, 2019 | 62.55% |
| March 31, 2019 | 64.16% |
| December 31, 2018 | 61.79% |
| September 30, 2018 | 60.85% |
| Date | Value |
|---|---|
| June 30, 2018 | 62.43% |
| March 31, 2018 | 59.61% |
| December 31, 2017 | 59.80% |
| September 30, 2017 | 63.51% |
| June 30, 2017 | 64.91% |
| March 31, 2017 | 66.52% |
| December 31, 2016 | 66.59% |
| September 30, 2016 | 64.32% |
| June 30, 2016 | 64.07% |
| March 31, 2016 | 64.20% |
| December 31, 2015 | 62.68% |
| September 30, 2015 | 61.98% |
| June 30, 2015 | 64.62% |
| March 31, 2015 | 62.86% |
| December 31, 2014 | 61.19% |
| September 30, 2014 | 62.59% |
| June 30, 2014 | 62.41% |
| March 31, 2014 | 61.69% |
| December 31, 2013 | 55.35% |
| September 30, 2013 | 61.66% |
| June 30, 2013 | 60.19% |
| March 31, 2013 | 59.52% |
| December 31, 2012 | 61.79% |
| September 30, 2012 | 62.14% |
| June 30, 2012 | 62.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
52.58%
Minimum
Sep 2024
63.59%
Maximum
Sep 2020
59.79%
Average
61.34%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Haemonetics Corp | 54.25% |
| ResMed Inc | 58.57% |
| Globus Medical Inc | 56.77% |
| Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.42% |
| Return on Assets | -0.17% |
| Return on Invested Capital | -0.20% |
| Profit Margin (Quarterly) | -2.81% |
| Operating Margin (Quarterly) | -2.14% |
| Return on Net Operating Assets | -0.19% |